Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin XVB (MYO15B) is a predicted unconventional myosin with ATP and actin binding as well as cytoskeletal motor activity, though its precise biological role remains uncharacterized in humans. The gene is annotated as a pseudogene (transcribed non-protein coding), with evidence of transcription but no confirmed protein or enzymatic function. It appears in pseudogene catalogs and is not identified as a functional therapeutic target, nor is it linked to any known disease roles or therapeutic applications. The majority of references to MYO15B correspond to predicted or uncharacterized proteins, alternative database entries, or pseudogenes, and not to an established receptor, enzyme, transporter, or disease-relevant target[1][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin XVB (MYO15B).